NCT03379064

Brief Summary

Irritable bowel syndrome (IBS) is a highly prevalent functional bowel disorder routinely encountered by healthcare providers although it's not life-threatening, this chronic disorder has ability to reduce patients' quality of life and imposes a significant economic burden to the healthcare system.Despite the high prevalence of IBS and its association with disability and adverse effect on health related quality of life we are not aware of any published trial of psychological intervention for IBS from Pakistan. We aim to test the feasibility and acceptability of culturally adapted Cognitive Behaviour Therapy (CBT) for the management of IBS in Karachi, Pakistan compared to treatment as usual.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 20, 2017

Completed
10 days until next milestone

Study Start

First participant enrolled

December 30, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2018

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2019

Completed
Last Updated

November 14, 2022

Status Verified

November 1, 2022

Enrollment Period

10 months

First QC Date

October 26, 2017

Last Update Submit

November 10, 2022

Conditions

Keywords

Irritable Bowel Syndrome, Low Income Country

Outcome Measures

Primary Outcomes (1)

  • IBS-symptom severity scale

    The score of this system is based on five items (severity and duration of pain, abdominal distension, bowel satisfaction, and interference with life in general) and uses visual analogue scales. Patients can be categorized as having mild (75-175), moderate (175-300), or severe (\>300) IBS.

    Change to baseline at 3rd Month

Secondary Outcomes (11)

  • IBS Rome III

    Baseline

  • IBS quality of Life III

    Baseline & 3rd Month

  • IBS pain scale-Pain Vigilance and Awareness Questionnaire

    Baseline & 3rd Month

  • Brief Disability Questionnaire (BDQ)

    Baseline & 3rd Month

  • Client Satisfaction Questionnaire

    3rd month

  • +6 more secondary outcomes

Study Arms (2)

culturally adapted Cognitive Behavior Therapy

EXPERIMENTAL

We will use The STreSS CBT manual developed by Schroder and his colleagues

Behavioral: Culturally adapted Cognitive Behavior Therapy for IBS

Treatment As Usual

NO INTERVENTION

The Treatment As Usual (TAU) group will receive regular treatment they have been receiving already as prescribed by the physician.

Interventions

Culturally adapted Cognitive Behavior Therapy for IBS

culturally adapted Cognitive Behavior Therapy

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Individuals with ROME 111 diagnoses of IBS
  • Between the age bracket of 18 to 55 years.
  • willing to give written informed consent.

You may not qualify if:

  • Individuals with atypical symptoms (rectal bleeding, anaemia or unexplained weightloss).
  • Diagnosis of inflammatory bowel disease, celiac disease or colon cancer.
  • Pregnant or breast feeding.
  • History of drug, alcohol, or chemical abuse within 6 months prior to screening.
  • Metabolic dysfunction, serious physical examination finding, or clinical laboratory finding giving reasonable suspicion that it might affect the interpretation of the re-sults or render the patient at high risk from treatment complication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Abasi Shaheed Hospital

Karachi, Sindh, 72000, Pakistan

Location

MeSH Terms

Conditions

Irritable Bowel Syndrome

Condition Hierarchy (Ancestors)

Colonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Prof. Nusrat Husain

    University of Manchester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2017

First Posted

December 20, 2017

Study Start

December 30, 2017

Primary Completion

October 20, 2018

Study Completion

May 30, 2019

Last Updated

November 14, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations